GB1087015A - Compounds for treating coccidiosis - Google Patents
Compounds for treating coccidiosisInfo
- Publication number
- GB1087015A GB1087015A GB26625/65A GB2662565A GB1087015A GB 1087015 A GB1087015 A GB 1087015A GB 26625/65 A GB26625/65 A GB 26625/65A GB 2662565 A GB2662565 A GB 2662565A GB 1087015 A GB1087015 A GB 1087015A
- Authority
- GB
- United Kingdom
- Prior art keywords
- chloro
- quinazolinone
- acid
- bromo
- prepared
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 208000003495 Coccidiosis Diseases 0.000 title abstract 2
- 206010023076 Isosporiasis Diseases 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 239000002253 acid Substances 0.000 abstract 5
- AVRPFRMDMNDIDH-UHFFFAOYSA-N 1h-quinazolin-2-one Chemical class C1=CC=CC2=NC(O)=NC=C21 AVRPFRMDMNDIDH-UHFFFAOYSA-N 0.000 abstract 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 abstract 3
- 229910052801 chlorine Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 2
- HVPQMLZLINVIHW-UHFFFAOYSA-N 6-bromo-1h-indole-2,3-dione Chemical compound BrC1=CC=C2C(=O)C(=O)NC2=C1 HVPQMLZLINVIHW-UHFFFAOYSA-N 0.000 abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 2
- 230000001165 anti-coccidial effect Effects 0.000 abstract 2
- 229910052794 bromium Inorganic materials 0.000 abstract 2
- 229910052731 fluorine Inorganic materials 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 238000010438 heat treatment Methods 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 abstract 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- JYYLQSCZISREGY-UHFFFAOYSA-N 2-amino-4-chlorobenzoic acid Chemical compound NC1=CC(Cl)=CC=C1C(O)=O JYYLQSCZISREGY-UHFFFAOYSA-N 0.000 abstract 1
- TUDNMLBIHIWVJM-UHFFFAOYSA-N 2-amino-5-bromo-4-chlorobenzoic acid Chemical compound NC1=CC(Cl)=C(Br)C=C1C(O)=O TUDNMLBIHIWVJM-UHFFFAOYSA-N 0.000 abstract 1
- VTFCXMNTJYSFIR-UHFFFAOYSA-N 2-amino-5-chloro-4-fluorobenzoic acid Chemical compound NC1=CC(F)=C(Cl)C=C1C(O)=O VTFCXMNTJYSFIR-UHFFFAOYSA-N 0.000 abstract 1
- GLZQDDOVGRLCHY-UHFFFAOYSA-N 5-chloro-6-fluoro-1h-indole-2,3-dione Chemical compound C1=C(Cl)C(F)=CC2=C1C(=O)C(=O)N2 GLZQDDOVGRLCHY-UHFFFAOYSA-N 0.000 abstract 1
- QZTCAFOLXYDQKO-UHFFFAOYSA-N 6,7-dichloro-3-[3-(3-hydroxypiperidin-2-yl)-2-oxopropyl]quinazolin-4-one hydrobromide Chemical compound Br.ClC=1C=C2C(N(C=NC2=CC1Cl)CC(=O)CC1NCCCC1O)=O QZTCAFOLXYDQKO-UHFFFAOYSA-N 0.000 abstract 1
- VILDUFSHBWCWIF-UHFFFAOYSA-N 6-bromo-5-chloro-1h-indole-2,3-dione Chemical compound C1=C(Br)C(Cl)=CC2=C1NC(=O)C2=O VILDUFSHBWCWIF-UHFFFAOYSA-N 0.000 abstract 1
- ZTNDXMBXYIXSDC-UHFFFAOYSA-N 6-chloro-7-fluoro-3H-quinazolin-4-one Chemical compound ClC=1C=C2C(NC=NC2=CC1F)=O ZTNDXMBXYIXSDC-UHFFFAOYSA-N 0.000 abstract 1
- CWVFOAVBTUHQCZ-UHFFFAOYSA-N 6-fluoro-1h-indole-2,3-dione Chemical compound FC1=CC=C2C(=O)C(=O)NC2=C1 CWVFOAVBTUHQCZ-UHFFFAOYSA-N 0.000 abstract 1
- RDNHCLJTFRYDNA-UHFFFAOYSA-N Br.BrC=1C=C2C(N(C=NC2=CC1Br)CC(=O)CC1NCCCC1O)=O Chemical class Br.BrC=1C=C2C(N(C=NC2=CC1Br)CC(=O)CC1NCCCC1O)=O RDNHCLJTFRYDNA-UHFFFAOYSA-N 0.000 abstract 1
- YLIYZXLFVALMTJ-UHFFFAOYSA-N ClC=1C=C2C(N(C=NC2=CC1Cl)CC(=O)CC1NCCCC1OC(C)=O)=O Chemical compound ClC=1C=C2C(N(C=NC2=CC1Cl)CC(=O)CC1NCCCC1OC(C)=O)=O YLIYZXLFVALMTJ-UHFFFAOYSA-N 0.000 abstract 1
- 229960000583 acetic acid Drugs 0.000 abstract 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 abstract 1
- 239000003674 animal food additive Substances 0.000 abstract 1
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical class NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 229940124536 anticoccidial agent Drugs 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 239000003651 drinking water Substances 0.000 abstract 1
- 235000020188 drinking water Nutrition 0.000 abstract 1
- 239000012362 glacial acetic acid Substances 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- -1 nitro, phenyl Chemical group 0.000 abstract 1
- 150000003246 quinazolines Chemical class 0.000 abstract 1
- 150000003456 sulfonamides Chemical class 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Fodder In General (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US383910A US3320124A (en) | 1964-07-20 | 1964-07-20 | Method for treating coccidiosis with quinazolinones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1087015A true GB1087015A (en) | 1967-10-11 |
Family
ID=23515259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB26625/65A Expired GB1087015A (en) | 1964-07-20 | 1965-06-23 | Compounds for treating coccidiosis |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3320124A (cg-RX-API-DMAC10.html) |
| BR (1) | BR6571429D0 (cg-RX-API-DMAC10.html) |
| DE (1) | DE1545551B2 (cg-RX-API-DMAC10.html) |
| ES (1) | ES315612A1 (cg-RX-API-DMAC10.html) |
| FR (1) | FR1550956A (cg-RX-API-DMAC10.html) |
| GB (1) | GB1087015A (cg-RX-API-DMAC10.html) |
| IL (1) | IL23717A (cg-RX-API-DMAC10.html) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2339402A1 (fr) * | 1976-01-29 | 1977-08-26 | Roussel Uclaf | Nouvelle quinazolinone et ses sels, leurs procede de preparation et leur application comme medicament |
| DE2934069A1 (de) * | 1979-08-23 | 1981-03-12 | Hoechst Ag, 6000 Frankfurt | Mittel gegen theileriosen und seine verwendung. |
| FR2467630A1 (fr) * | 1979-10-23 | 1981-04-30 | Roussel Uclaf | Nouvelles resines echangeuses d'ions du type acide, leur procede de preparation et leur application comme medicament |
| US4364928A (en) * | 1979-10-23 | 1982-12-21 | Roussel-Uclaf | Novel salts of ion exchange resins of the acid type |
| US4725599A (en) * | 1986-09-08 | 1988-02-16 | Pfizer Inc. | Heterocyclic ring fused pyrimidine-4 (3H)-ones as anticoccidial agents |
| US4797486A (en) * | 1986-09-08 | 1989-01-10 | Pfizer Inc. | Heterocyclic ring fused pyrimidine-4(3H)-ones as anticoccidial agents |
| US5314700A (en) * | 1991-01-28 | 1994-05-24 | Ethyl Corporation | Poultry feed component |
| CA2113229C (en) * | 1994-01-11 | 1999-04-20 | Mark Pines | Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof |
| IL110831A (en) * | 1994-08-31 | 1998-12-27 | Hadasit Med Res Service | Pharmaceutical compositions containing quinazolinone derivatives for preventing restenosis |
| IL112125A (en) * | 1994-12-22 | 1998-02-08 | Hadasit Med Res Service | Quinazolinone-containing pharmaceutical compositions |
| IL114951A (en) * | 1995-08-15 | 1999-08-17 | Hadasit Med Res Service | Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization |
| US6090814A (en) * | 1995-08-15 | 2000-07-18 | Agricultural Research Organization Ministry Of Agriculture | Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization |
| EP0936910B1 (en) * | 1996-08-30 | 2002-07-24 | Agricultural Research Organization, Ministry Of Agriculture, State Of Israel | Intracoronary stents containing quinazolinone derivatives |
| US6028075A (en) | 1997-02-11 | 2000-02-22 | Pines; Mark | Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies |
| US6562829B1 (en) | 1997-05-23 | 2003-05-13 | Hadasit Medical Research Services & Development Co., Ltd. | Treatment of hepatic cirrhosis |
| IL132848A (en) * | 1997-05-23 | 2004-08-31 | Israel State | Preparation for the treatment of fetal cirrhosis |
| US6159488A (en) * | 1997-08-14 | 2000-12-12 | Agricultural Research Org. Ministry Of Agriculture (Gov.) | Intracoronary stents containing quinazolinone derivatives |
| ES2255286T3 (es) * | 1998-08-13 | 2006-06-16 | HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT CO., LTD. | Inhibicion de los procesos patogenicos relacionados con las lesiones del tejido. |
| US6545004B1 (en) | 1999-10-27 | 2003-04-08 | Cytokinetics, Inc. | Methods and compositions utilizing quinazolinones |
| US7230000B1 (en) | 1999-10-27 | 2007-06-12 | Cytokinetics, Incorporated | Methods and compositions utilizing quinazolinones |
| IL143366A0 (en) * | 2001-05-24 | 2002-04-21 | Harasit Medical Res Services & | Treatment of renal fibrosis |
| AU2002346471A1 (en) * | 2001-11-20 | 2003-06-10 | Cytokinetics, Inc. | Process for the racemization of chiral quinazolinones |
| IL147416A (en) * | 2001-12-31 | 2008-11-26 | Israel State | Combined modalities for improved cancer treatment |
| US7009049B2 (en) * | 2002-02-15 | 2006-03-07 | Cytokinetics, Inc. | Syntheses of quinazolinones |
| IL148292A (en) * | 2002-02-21 | 2008-08-07 | Shai Yarkoni | Stable preparations of lupoginone and other quinazolinone derivatives |
| AU2003270015A1 (en) | 2002-05-09 | 2003-12-02 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| US7166595B2 (en) * | 2002-05-09 | 2007-01-23 | Cytokinetics, Inc. | Compounds, methods and compositions |
| WO2003103575A2 (en) * | 2002-05-23 | 2003-12-18 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| CA2489367A1 (en) * | 2002-06-14 | 2003-12-24 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| WO2004009036A2 (en) * | 2002-07-23 | 2004-01-29 | Cytokinetics, Inc. | Compounds compositions and methods |
| EP1539180A4 (en) * | 2002-08-21 | 2006-08-30 | Cytokinetics Inc | COMPOUNDS, COMPOSITIONS AND METHODS |
| WO2004034972A2 (en) * | 2002-09-30 | 2004-04-29 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| JP2007510652A (ja) * | 2003-11-03 | 2007-04-26 | サイトキネティクス・インコーポレーテッド | ピリミジン−４−オン化合物、組成物、および方法 |
| WO2005046588A2 (en) * | 2003-11-07 | 2005-05-26 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| EP1692112A4 (en) * | 2003-12-08 | 2008-09-24 | Cytokinetics Inc | COMPOUNDS, COMPOSITIONS, AND METHODS |
| CN1304391C (zh) * | 2004-02-06 | 2007-03-14 | 上海因诺生化科技有限公司 | 氢溴酸常山酮的制备方法 |
| JP2008531547A (ja) * | 2005-02-23 | 2008-08-14 | コルガード バイオファーマシューティカルズ リミテッド | キナゾリノン誘導体であるハロフジノンの単離されたｄ−エナンチオマーの医薬組成物 |
| WO2007120606A2 (en) * | 2006-04-10 | 2007-10-25 | President And Fellows Of Harvard College | Methods for modulating formation and progression of cellulite |
| MX2009005252A (es) * | 2006-11-17 | 2009-05-28 | Abbott Lab | Aminopirrolidinas como antagonistas del receptor de quimiocina. |
| US8410120B2 (en) | 2007-01-21 | 2013-04-02 | Mark Pines | Composition and method for treating or preventing skeletal muscle fibrosis |
| WO2009023267A2 (en) * | 2007-08-15 | 2009-02-19 | President And Fellows Of Harvard College | Methods for modulating development and expansion of il-17 expressing cells |
| US20090123389A1 (en) * | 2007-08-15 | 2009-05-14 | Malcolm Whitman | Methods for modulating Th17 cell development in the treatment and prevention of cellulite |
| FR2922451A1 (fr) * | 2007-10-23 | 2009-04-24 | Windgan Trading | Traitement des retrecissements de l'uretre |
| CA2737219C (en) * | 2008-08-11 | 2017-02-28 | Tracy Keller | Halofuginone analogs for inhibition of trna synthetases and uses thereof |
| US8357692B2 (en) | 2010-06-20 | 2013-01-22 | Washington University | Methods of treatment of bone degenerative diseases |
| CA2861840C (en) | 2012-01-13 | 2020-12-15 | President And Fellows Of Harvard College | Halofuginol derivatives and their use in cosmetic and pharmaceutical compositions |
| WO2019237125A1 (en) | 2018-06-08 | 2019-12-12 | The General Hospital Corporation | Inhibitors of prolyl-trna-synthetase |
| CN111233831A (zh) * | 2020-03-18 | 2020-06-05 | 郑州市华农兽药研究院 | 常山铜琥珀酸单酯及其制备方法与用途 |
| CN112409272B (zh) * | 2020-11-26 | 2025-09-16 | 河北美荷药业有限公司 | 一种6-氯-7-溴-4（3h）-喹唑啉酮的制备方法和应用 |
-
1964
- 1964-07-20 US US383910A patent/US3320124A/en not_active Expired - Lifetime
-
1965
- 1965-06-11 IL IL23717A patent/IL23717A/xx unknown
- 1965-06-23 GB GB26625/65A patent/GB1087015A/en not_active Expired
- 1965-07-19 BR BR171429/65A patent/BR6571429D0/pt unknown
- 1965-07-20 FR FR1550956D patent/FR1550956A/fr not_active Expired
- 1965-07-20 DE DE1965A0049791 patent/DE1545551B2/de active Granted
- 1965-07-20 ES ES0315612A patent/ES315612A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BR6571429D0 (pt) | 1973-08-14 |
| US3320124A (en) | 1967-05-16 |
| IL23717A (en) | 1971-01-28 |
| FR1550956A (cg-RX-API-DMAC10.html) | 1968-12-27 |
| DE1545551B2 (de) | 1976-12-23 |
| ES315612A1 (es) | 1966-07-01 |
| DE1545551A1 (de) | 1969-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES485064A1 (es) | Un procedimiento para preparar derivados de acido acetico | |
| PT80546B (en) | Process for the preparation of quinolinecarboxylic acid derivatives | |
| GB1095784A (en) | Benzothioxanthene dyestuffs and processes for their manufacture | |
| GB1066604A (en) | New pyrrole derivatives and process for their manufacture | |
| ES8105321A1 (es) | Un procedimiento para la preparacion de nuevos derivados de quinazolina | |
| JPS5492946A (en) | 2-aminomethylphenol derivative and its production | |
| ES291973A2 (es) | Proceso para la preparaciën de nuevas penicilinas | |
| GB1347374A (en) | Oxazolo-4,5-b pyridine derivatives | |
| GB1370028A (en) | Substituted indenyl acetic acid derivatives | |
| SU419028A3 (ru) | Способ получения 2- | |
| Elderfield et al. | 3-Phenyl-4-chloro-and 3-Phenyl-4, 7-dichloroquinoline1 | |
| ES344387A1 (es) | Procedimiento para la obtencion de piridil-dihidroisoquino-leinas. | |
| KR930003072B1 (ko) | 퀴놀론카복실산 유도체의 제조방법 | |
| US3374239A (en) | 6-chloro-2-(5-nitro-2-furyl) cinchoninic acid | |
| GB1197251A (en) | N-Phenyl p-Chlorobenzamide Derivatives and their Conversion to Indolyl Acetic Acid Derivatives | |
| Moustafa et al. | Synthesis and antimicrobial activity of novel furothienoquinoxalines, pyranothienoquinoxalines and pyrimidopyranothienoquinoxalines | |
| Sato et al. | Synthesis of Evolitrine, an Alkaloid of Evodia littoralis | |
| US3471507A (en) | New isothiazole synthesis | |
| GB1377306A (en) | Esters of 2-quinoxalinecarboxylic acid di n-oxide | |
| DE1951828A1 (de) | Verfahren zur Bekaempfung der Coccidiose bei Gefluegel und neue Verbindungen zur Verwendung in diesem Verfahren | |
| IE37153L (en) | 3-aryl-2-halothiopropionic acids | |
| JPS5564575A (en) | Preparation of 3-acyl-5-fluorouracil | |
| SU443036A1 (ru) | Способ получени ароматических и гетероциклических производных симмтриазина | |
| GB1515064A (en) | Antibacterial 1,3-dihydrofuro(3,4-b)quinoxaline 4,9-dioxides | |
| GB1303372A (cg-RX-API-DMAC10.html) |